
Featured
Pfizer Showcases AI-Powered Cancer Research at ASCO 2026
Pfizer unveils AI-powered cancer research at ASCO 2026, highlighting precision oncology, ADC therapies, and next-generation treatments.
Lila•Invalid Date
3 articles tagged

Pfizer unveils AI-powered cancer research at ASCO 2026, highlighting precision oncology, ADC therapies, and next-generation treatments.

Eli Lilly’s retatrutide delivered up to 30% weight loss in Phase 3 obesity trials, outperforming Wegovy and other GLP-1 therapies.

Novo Nordisk is using AI in India to speed up obesity drug launches, regulatory filings, and oral Wegovy development globally.